Theracle
PrivateLast Round
VC Round
Oct 6, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Theracle is a medical technology company developing an implantable drug-delivery platform designed to bypass the blood-brain barrier for the treatment of neurological conditions and brain cancers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theracle Comparables
Compare Theracle with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cognos Therapeutics Inc | 86% | |
| CraniUS Therapeutics | 85% | |
| Carthera | 78% | |
Theracle Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 6, 2025 | ||||
| Accelerator | May 2, 2013 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 6, 2025
Raised a VC Round with participation from Neuroceuticals Inc.
- May 2, 2013
Accelerator round led by InCube Labs
Theracle Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Theracle's valuation, stock price, and market status.